To subscribe to the Cleveland Clinic’s Rheumatology Connections eNewsletter, please visit [ Ссылка ]
Learn why there a rapid decline in bone density when Denosumab is discontinued as discussed by rheumatologist Chad Deal, MD.
Dr. Deal is the Head of the Center for Osteoporosis and Metabolic Bone Disease, Cleveland Clinic. To learn more about him, please visit [ Ссылка ]
If you’re experiencing a health issue, don’t delay. Call 216.444.2606 to make an appointment with a Cleveland Clinic rheumatologic specialist or view a list of specialists at [ Ссылка ]
If you liked the video hit like and subscribe for more!
#clevelandclinic #rheumatology #casestudy
Denosumab Discontinuation
Теги
rheumatology case studiesimmunologybone densitydenosumabchad dealrapid increase in bone absorptionside-effectsincrease fracture risktrials of denosumabcleveland clinicrheumatologycleveland clinic case studiescleveland clinic case studyrheumatology case studyrheumatologistchad deal cleveland clinic case studyrheumatologic case studieschad deal cleveland cliniccase study4377dr. chad dealchad deal md